Medusa is selected for $2.6m in funding for the next generation of Siren ePCR Suite.
20:29 18 June
in Siren ePCR Suite
Medusa Medical Technologies Inc. is pleased to announce that it has been selected for funding through the ACOA Atlantic Innovation Fund. Medusa’s proposal for $2,625,000 of AIF funding has been accepted. The funding will be 75% of a $3.5 million project to improve Medusa’s Siren...